Tangen Biosciences Awarded a Contract for Point-of-Care Detection of Candida auris
According to the CDC, New York State has the most Candida auris cases in the United States.
- According to the CDC, New York State has the most Candida auris cases in the United States.
- Tangen will independently develop a skin-swab based Candida auris assay running on its portable GeneSparkTM instrument and will also develop a swab-based Candida auris test for environmental surveillance.
- Tangens new contract with Wadsworth Center is expected to further expand Tangens product pipeline to include a clinical as well as an environmental Candida auris test.
- Current tests in development include COVID-19, Candida auris, sepsis causing bacteria, antibiotic resistance genes, and a Candida blood panel.